<DOC>
	<DOCNO>NCT02138773</DOCNO>
	<brief_summary>The purpose study investigate relative bioavailability two type prolong release formulation tamsulosin hydrochloride Chinese healthy subject . The safety tamsulosin formulation also compare .</brief_summary>
	<brief_title>A Study Compare How Tamsulosin Absorbed Body After Administration Two Types Tamsulosin Formulation Under Fed Fasted Conditions Chinese Healthy Subjects</brief_title>
	<detailed_description>There two study . One study conduct fed condition , study conduct fasted condition . Each study single center , randomize , single dose , open-labeled , cross-over study . Study 1 conduct fed condition : Subjects undergo screen evaluation determine eligibility within 7 day prior study enrollment . Subjects admit clinical facility even prior dosing period . All subject receive tamsulosin formulation-A formulation-B one two randomly assign treatment sequence 0.5h start standard breakfast . There 7-day washout period dose . Study 2 fast condition : A single oral dose tamsulosin formulation-A formulation-B give subject fast condition ( fast least 10 hour since 20:00PM night administration ) . Blood sample time point Study 1 . Also , safety evaluation perform select time throughout study Study 1 .</detailed_description>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Body Mass Index ( BMI=weight ( kg ) /height ( ) 2 ) 19 24 ( include ) Body weight less 50 kg Healthy determine clinically significant deviation normal medical history , physical examination , ECGs clinical laboratory determination Subject receive drug treatment ( include OTC ) within 4 week prior first administration Subject know suspected history allergic condition and/or hypersensitivity Tamsulosin , excipients drug product drug class Existing cardiac , haematological , hepatic , renal , gastrointestinal acute chronic disease and/or pathological finding , might interfere drug 's safety , tolerability , absorption and/or pharmacokinetics Subject symptomatic hypotension whatever decrease blood pressure asymptomatic postural hypotension define decrease SBP DBP equal great 20mmHg within two minute change supine stand position Subject sit DBP &lt; 60mmHg &gt; 90mmHg , and/or SBP &lt; 90mmHg &gt; 140mmHg , and/or pulse rate ( PR ) &lt; 40/min &gt; 90/min , and/or axilla temperature &gt; 37℃ &lt; 35℃ within screen period Subject previous history drug abuse subject show degree drug abuse within 3 month prior present study Subject blood donation plasma loss 200mL receive transfusion blood blood product within 3 month prior start present study Subject treatment plasma exchange within 4 week prior present study Subject participate study within 3 month prior present study , participate 3 study last 12 month prior start present study Subject HBsAg , HCVAb HIVAb Subject partner wish become pregnant present study period 30 day study Subject mentally physically disabled</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>prolonged release formulation</keyword>
	<keyword>adrenergic blocker</keyword>
	<keyword>Bioequivalence</keyword>
</DOC>